SGI
NEO icon

Summit Global Investments’s NeoGenomics NEO Stock Holding History

Summit Global Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-24,300
Closed -$753K – 261
2020
Q2 		$753K Buy
24,300
+200
+0.8% +$5.54K 0.09% 148
2020
Q1 		$665K Buy
+24,100
New +$722K 0.1% 134

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Summit Global Investments's NEO Position: Q3 2020 in Review

Summit Global Investments sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 24,300 shares — an estimated $753K sold.

Summit Global Investments first reported a position in NEO in Q1 2020 and held it in 2 quarters. The position peaked at $753K in Q2 2020. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

  • Summit Global Investments reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
  • Summit Global Investments sold 24,300 NeoGenomics shares in Q3 2020, an estimated $753K.
  • Summit Global Investments first reported a position in NeoGenomics in Q1 2020 and held it in 2 quarters.
  • Summit Global Investments's NeoGenomics position peaked at $753K in Q2 2020.
  • 294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on Summit Global Investments's 13F filing for Q3 2020, filed 16 Nov 2020.